The Surviving Sepsis Campaign Guidelines 2021 recommend norepinephrine (NE) as the first-line vasopressor for septic shock; for patients with inadequate mean arterial pressure (MAP) < 65 mmHg, arginine vasopressin (AVP) should be added rather than increasing the NE dose [5]. This evidence concerns the gene AVP and Sepsis.